The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice

The most frequent site of recurrence in breast cancer (BC) is the bone, particularly in patients with ‘luminal-like’ disease. Denosumab has been shown to prevent aromatase inhibitors (AIs) induced bone resorption in postmenopausal early BC patients and reduce skeletal-related events (SREs) in bone m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortellini, Alessio, Cocciolone, Valentina, Irelli, Azzurra, Pavese, Francesco, Sidoni, Tina, Parisi, Alessandro, Lanfiuti Baldi, Paola, Venditti, Olga, D'Orazio, Carla, Bonfili, Pierluigi, Franzese, Pietro, Zugaro, Luigi, Verna, Lucilla, Porzio, Giampiero, Santini, Daniele, Cannita, Katia, Ficorella, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256706/
https://www.ncbi.nlm.nih.gov/pubmed/30546457
http://dx.doi.org/10.3892/ol.2018.9561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256706/
https://www.ncbi.nlm.nih.gov/pubmed/30546457
http://dx.doi.org/10.3892/ol.2018.9561

Ejemplares similares